To make high quality generics available and affordable
Sudamed Pharma is an innovative pharmaceutical company established by highly qualified Sudanese British healthcare professionals committed to address the gap in medicine supply in Sudan and therefore improve access to healthcare.
To make high quality generics available and affordable
Sudamed Pharma is an innovative pharmaceutical company established by highly qualified Sudanese British healthcare professionals committed to address the gap in medicine supply in Sudan and therefore improve access to healthcare.
Our Core Focus
Quality
Ethics
Patient safety
Social Responsibility
Innovation
Mobilizing Resources
Sustainability
Better access
better health
Our Core Focus
Quality
Ethics
Patient safety
Social Responsibility
Innovation
Mobilizing Resources
Sustainability
Better access
better health
01
Generic medicines are equally safe, effective and has same quality as originator brands.
02
Generics have to demonstrate that they are bio equivalent to the original product- i.e., they deliver equal medical benefits to the patient.
03
Generic medications are cost effective. For instances, in 2020 alone Sudan could have saved 5 million Euros by switching one cardiovascular agent to its bioequivelant generic.
10 things you need to know
04
Sudan large population (45M) is advantageous for short, medium and long-term pharmaceutical demand.
05
Sudanese economy is now open and is increasingly becoming attractive for foreign investment specially in healthcare
06
Sudan pharmaceutical market suffers severe shortages. For instance National Medicines and Poisons Board NMPB has recently published a list of sever shortage medications which contained 1000 products
07
Strategic geographical position of Sudan makes it a gateway to neighboring countries. Africa’s pharmaceutical market is still growing with high potential, value of Africa's pharmaceutical industry jumped to USD 28.56 billion in 2017 from just USD 5.5 billion a decade earlier. Sudan market size is projected to reach 1 billion USD in the next few years.
08
National Medicines Supplies Fund NMSF, which is the main governmental medicines procurement body in Sudan, encourages purchases of high quality generics from SRA countries which would be a great chance for our perspective principles
09
National Medicines and Poisons Board NMPB, which is the regulatory body in Sudan, has opened a fast track for registering UK and European manufactured medications
10
There is fast growing presence of high quality European /UK generic medications in the Sudanese market and partnering with Sudamed Pharma to have an early foot step i would be great investment in this emerging market.
